Astrana Health (NASDAQ:ASTH) Shares Down 2.7% – Here’s What Happened

Astrana Health, Inc. (NASDAQ:ASTH) fell 2.7% on Tuesday . The stock traded as low as $32.58 and last traded at $32.58. 44,044 shares were traded during mid-day trading, a decline of 80% from the average session volume of 217,443 shares. The stock had previously closed at $33.47.

Analysts Set New Price Targets

A number of research firms have commented on ASTH. Macquarie raised shares of Astrana Health to a “hold” rating in a report on Monday, December 16th. KeyCorp assumed coverage on shares of Astrana Health in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. TD Cowen began coverage on Astrana Health in a report on Monday, October 14th. They set a “buy” rating and a $66.00 target price on the stock. BTIG Research boosted their price objective on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research report on Thursday, October 3rd. Finally, Robert W. Baird lifted their price target on shares of Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research note on Wednesday, November 13th. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $65.17.

Astrana Health Stock Performance

The stock has a market capitalization of $1.88 billion, a P/E ratio of 25.75, a PEG ratio of 1.80 and a beta of 1.14. The stock’s 50-day simple moving average is $46.70 and its 200 day simple moving average is $47.86. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.33 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.33. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The company had revenue of $478.71 million during the quarter, compared to analysts’ expectations of $462.01 million. During the same quarter in the previous year, the company posted $0.47 earnings per share. Research analysts expect that Astrana Health, Inc. will post 1.16 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Janus Henderson Group PLC purchased a new stake in Astrana Health in the 3rd quarter valued at $1,164,000. Royce & Associates LP bought a new stake in Astrana Health during the 3rd quarter worth approximately $6,661,000. Amalgamated Bank purchased a new position in shares of Astrana Health during the third quarter worth about $713,000. Principal Financial Group Inc. bought a new stake in shares of Astrana Health during the 3rd quarter worth $13,383,000. Finally, Diamond Hill Capital Management Inc. bought a new stake in shares of Astrana Health in the 3rd quarter worth approximately $8,245,000. Institutional investors own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.